Categories AlphaGraphs, Earnings, LATEST, Retail

Shopify’s Q2 results beat expectations

Shopify Inc. (NYSE: SHOP) beat market expectations for revenue and earnings in the second quarter of 2019, sending the stock climbing over 7% in premarket hours on Thursday.

Total revenue increased 48% year-over-year to $362 million, beating estimates of $350 million.  

Shopify beat market estimates for revenue and earnings in Q2 2019

GAAP net loss was $28.7 million, or $0.26 per share, compared with $24 million, or $0.23 per share, in the year-ago period. Adjusted net income totaled $15.8 million, or $0.14 per share, topping forecasts of $0.03 per share.  

During the quarter, Subscription Solutions revenue rose 38% to $153 million, driven by higher Monthly Recurring Revenue (MRR) as a result of more merchants joining the Shopify platform. Merchant Solutions revenue grew 56% to $209 million, driven by growth in Gross Merchandise Volume (GMV), Shopify Capital and Shopify Shipping.    

At quarter-end, MRR was $47.1 million, up 34% from the same period last year, with a 26% contribution from Shopify Plus versus 23% last year. GMV grew 51% to $13.8 billion while Gross Payments Volume (GPV) rose to $5.8 billion, accounting for 42% of GMV processed during the quarter.  

Purchases from merchants’ stores coming from mobile devices versus desktop increased during the quarter, accounting for around 80% of traffic and 70% of orders for the second quarter, versus 76% and 66%, respectively, for the same period last year.

Shopify expects revenues of $377 million to $382 million for the third quarter of 2019. The company raised its full-year 2019 revenue outlook to a range of $1.51 billion to $1.53 billion versus the prior range of $1.48 billion to $1.50 billion.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top